BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12647789)

  • 1. Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas.
    Trovato M; Grosso M; Vitarelli E; Ruggeri RM; Alesci S; Trimarchi F; Barresi G; Benvenga S
    Histol Histopathol; 2003 Apr; 18(2):393-9. PubMed ID: 12647789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules.
    Trovato M; Villari D; Bartolone L; Spinella S; Simone A; Violi MA; Trimarchi F; Batolo D; Benvenga S
    Thyroid; 1998 Feb; 8(2):125-31. PubMed ID: 9510120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HGF/C-MET system pathways in benign and malignant histotypes of thyroid nodules: an immunohistochemical characterization.
    Ruggeri RM; Vitarelli E; Barresi G; Trimarchi F; Benvenga S; Trovato M
    Histol Histopathol; 2012 Jan; 27(1):113-21. PubMed ID: 22127603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of HGF, c-MET and transcription factor STAT3 in colorectal tumors.
    Trovato M; Vitarelli E; Grosso M; Alesci S; Benvenga S; Trimarchi F; Barresi G
    Eur J Histochem; 2004; 48(3):291-7. PubMed ID: 15590419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.
    Ruggeri RM; Villari D; Simone A; Scarfi R; Attard M; Orlandi F; Barresi G; Trimarchi F; Trovato M; Benvenga S
    J Endocrinol Invest; 2002 Dec; 25(11):959-66. PubMed ID: 12553555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CITED1 protein expression suggests Papillary Thyroid Carcinoma in high throughput tissue microarray-based study.
    Prasad ML; Pellegata NS; Kloos RT; Barbacioru C; Huang Y; de la Chapelle A
    Thyroid; 2004 Mar; 14(3):169-75. PubMed ID: 15072698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Met expression of thyroid tissue with special reference to papillary carcinoma.
    Oyama T; Ichimura E; Sano T; Kashiwabara K; Fukuda T; Nakajima T
    Pathol Int; 1998 Oct; 48(10):763-8. PubMed ID: 9788259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases.
    Belfiore A; Gangemi P; Costantino A; Russo G; Santonocito GM; Ippolito O; Di Renzo MF; Comoglio P; Fiumara A; Vigneri R
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2322-8. PubMed ID: 9215314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma.
    Ramirez R; Hsu D; Patel A; Fenton C; Dinauer C; Tuttle RM; Francis GL
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):635-44. PubMed ID: 11106926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
    Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis.
    Ruco LP; Stoppacciaro A; Ballarini F; Prat M; Scarpino S
    J Pathol; 2001 May; 194(1):4-8. PubMed ID: 11329134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostaining for Met/HGF receptor may be useful to identify malignancies in thyroid lesions classified suspicious at fine-needle aspiration biopsy.
    Ippolito A; Vella V; La Rosa GL; Pellegriti G; Vigneri R; Belfiore A
    Thyroid; 2001 Aug; 11(8):783-7. PubMed ID: 11525273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tyrosine kinase receptor c-met, its cognate ligand HGF and the tyrosine kinase receptor trasducers STAT3, PI3K and RHO in thyroid nodules associated with Hashimoto's thyroiditis: an immunohistochemical characterization.
    Ruggeri RM; Vitarelli E; Barresi G; Trimarchi F; Benvenga S; Trovato M
    Eur J Histochem; 2010 Jun; 54(2):e24. PubMed ID: 20558345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression of the hepatocyte growth factor (HGF), HGF-receptor (c-met) and STAT3 on placental tissues from malformed fetuses.
    Trovato M; Grosso M; Vitarelli E; Benvenga S; Trimarchi F; Barresi G
    Histol Histopathol; 2002; 17(3):691-8. PubMed ID: 12168776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.
    Mai KT; Ford JC; Yazdi HM; Perkins DG; Commons AS
    Pathol Res Pract; 2000; 196(8):533-40. PubMed ID: 10982016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules.
    Trovato M; Villari D; Ruggeri RM; Quattrocchi E; Fragetta F; Simone A; Scarfi R; Magro G; Batolo D; Trimarchi F; Benvenga S
    Thyroid; 2001 Jul; 11(7):621-8. PubMed ID: 11484890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of c-Met protein in human thyroid tumors correlated with lymph node metastasis and clinicopathologic stage.
    Chen BK; Ohtsuki Y; Furihata M; Takeuchi T; Iwata J; Liang SB; Sonobe H
    Pathol Res Pract; 1999; 195(6):427-33. PubMed ID: 10399184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in patterns of Met expression in papillary thyroid carcinomas and nonneoplastic thyroid tissue.
    Fluge Ø ; Haugen DR; Lillehaug JR; Varhaug JE
    World J Surg; 2001 May; 25(5):623-31. PubMed ID: 11369990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
    Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
    Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].
    He CN; He L; Cheng JQ; Chen SC; Zhao HF; Zhai JP; Zhang J
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):35-9. PubMed ID: 18509983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.